$2500 | Single User Price
$5000 | Site License Price
$7500 | Enterprise License Price

Childhood Epilepsy Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017]

Published by Global Data: 31 May 2017 | 105771 | In Stock

Introduction

Childhood Epilepsy Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H1, 2017" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Childhood Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Childhood Epilepsy Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Report Guidance 6

    GlobalData Clinical Trials Report Coverage 7

    Clinical Trials by Region 8

    Clinical Trials and Average Enrollment by Country 9

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Countries Contributing to Clinical Trials in Middle East and Africa 14

    Clinical Trials by G7 Countries: Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Childhood Epilepsy Therapeutics Clinical Trials 28

    Prominent Drugs 29

    Latest Clinical Trials News on Childhood Epilepsy 30

    May 05, 2017: Esperite, The Cell Factory demonstrate antiinflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy 30

    Apr 19, 2017: Sunovion to Present Data on Aptiom (eslicarbazepine acetate) at the American Academy of Neurology 2017 Annual Meeting 31

    Clinical Trial Profile Snapshots 32

    Appendix 130

    Abbreviations 130

    Definitions 130

    Research Methodology 131

    Secondary Research 131

    About GlobalData 132

    Contact Us 132

    Source 132

List Of Tables
in Childhood Epilepsy Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017]

List of Tables

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Region, 2017* 8

Childhood Epilepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Childhood Epilepsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11

Childhood Epilepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

Childhood Epilepsy Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

Childhood Epilepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14

Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15

Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18

Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Phase, 2017* 21

Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Childhood Epilepsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Childhood Epilepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26

Childhood Epilepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Childhood Epilepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Childhood Epilepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List Of Figures, Charts and Diagrams
in Childhood Epilepsy Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017]

List of Figures

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Region (%), 2017* 8

Childhood Epilepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Childhood Epilepsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11

Childhood Epilepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12

Childhood Epilepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13

Childhood Epilepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14

Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15

Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18

Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21

Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22

Childhood Epilepsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Childhood Epilepsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Childhood Epilepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26

Childhood Epilepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Childhood Epilepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Childhood Epilepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

GlobalData Methodology 131

Additional Details

Publisher

Global Data

Publisher Information

Reference

105771 | GDHC4272CTIDB

Number of Pages

132

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Autism Spectrum Disorder (ASD) Treatment Market: By Autism Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Childhood Disintegrative Disorder); By Treatment Approach (Behavioral Approaches, Early Intervention, Medication, Dietary Approach) & By Geography-Forecast (2016-2021)
Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized...
25 Mar 2016 by Industry ARC USD $5,250 More Info
Childhood Epilepsy Global Clinical Trials Review, H2, 2015
Childhood Epilepsy Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report,...
16 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Childhood Epilepsy Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data